97 related articles for article (PubMed ID: 31384397)
1. Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma.
Veeranki OL; Tong Z; Dokey R; Mejia A; Zhang J; Qiao Y; Singh PK; Katkhuda R; Mino B; Tailor R; Canales JR; Bassett R; Ajani J; Wu JY; Kopetz S; Blum M; Hofstetter W; Tetzlaff M; Krishnan S; Lin SH; Maru D
Oncotarget; 2019 Jul; 10(45):4703-4718. PubMed ID: 31384397
[TBL] [Abstract][Full Text] [Related]
2. Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma.
Tong Z; Mejia A; Veeranki O; Verma A; Correa AM; Dokey R; Patel V; Solis LM; Mino B; Kathkuda R; Rodriguez-Canales J; Lin SH; Krishnan S; Kopetz S; Blum M; Ajani JA; Hofstetter WL; Maru DM
Ther Adv Med Oncol; 2019; 11():1758835919864850. PubMed ID: 31384313
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.
Tong Z; Chatterjee D; Deng D; Veeranki O; Mejia A; Ajani JA; Hofstetter W; Lin S; Guha S; Kopetz S; Krishnan S; Maru D
Oncotarget; 2017 Apr; 8(17):28696-28710. PubMed ID: 28404924
[TBL] [Abstract][Full Text] [Related]
4. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma.
Ma H; Seebacher NA; Hornicek FJ; Duan Z
EBioMedicine; 2019 Jan; 39():182-193. PubMed ID: 30579871
[TBL] [Abstract][Full Text] [Related]
6. Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.
Shen S; Dean DC; Yu Z; Hornicek F; Kan Q; Duan Z
J Cancer; 2020; 11(1):132-141. PubMed ID: 31892980
[No Abstract] [Full Text] [Related]
7. Positive transcription elongation factor b (P-TEFb) is a therapeutic target in human multiple myeloma.
Zhang Y; Zhou L; Leng Y; Dai Y; Orlowski RZ; Grant S
Oncotarget; 2017 Aug; 8(35):59476-59491. PubMed ID: 28938651
[TBL] [Abstract][Full Text] [Related]
8. Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma.
Li X; Seebacher NA; Xiao T; Hornicek FJ; Duan Z
J Orthop Res; 2019 Feb; 37(2):510-521. PubMed ID: 30488489
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.
Shen Y; Zhang W; Liu J; He J; Cao R; Chen X; Peng X; Xu H; Zhao Q; Zhong J; Ding W; Lei X; Jiang Y; Zu X
Int J Cancer; 2019 Feb; 144(3):651-664. PubMed ID: 30289981
[TBL] [Abstract][Full Text] [Related]
10. Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.
Chukkapalli V; Gordon LI; Venugopal P; Borgia JA; Karmali R
Oncotarget; 2018 Apr; 9(30):21166-21181. PubMed ID: 29765528
[TBL] [Abstract][Full Text] [Related]
11. CDK9 is a prognostic marker and therapeutic target in pancreatic cancer.
Kretz AL; Schaum M; Richter J; Kitzig EF; Engler CC; Leithäuser F; Henne-Bruns D; Knippschild U; Lemke J
Tumour Biol; 2017 Feb; 39(2):1010428317694304. PubMed ID: 28231737
[TBL] [Abstract][Full Text] [Related]
12. Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells.
Nakajima M; Kawaguchi M; Matsuyama M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Int Arch Allergy Immunol; 2018; 176(2):83-90. PubMed ID: 29649811
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.
Teichman J; Dodbiba L; Thai H; Fleet A; Morey T; Liu L; McGregor M; Cheng D; Chen Z; Darling G; Brhane Y; Song Y; Espin-Garcia O; Xu W; Girgis H; Schwock J; MacKay H; Bristow R; Ailles L; Liu G
PLoS One; 2018; 13(5):e0194809. PubMed ID: 29715275
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.
Chen JL; Chen JP; Huang YS; Tsai YC; Tsai MH; Jaw FS; Cheng JC; Kuo SH; Shieh MJ
Strahlenther Onkol; 2016 Apr; 192(4):260-8. PubMed ID: 26952039
[TBL] [Abstract][Full Text] [Related]
16. The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells.
Storch K; Cordes N
Int J Oncol; 2016 Jan; 48(1):191-8. PubMed ID: 26573875
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes.
Kaichi S; Takaya T; Morimoto T; Sunagawa Y; Kawamura T; Ono K; Shimatsu A; Baba S; Heike T; Nakahata T; Hasegawa K
J Cell Physiol; 2011 Jan; 226(1):248-54. PubMed ID: 20665673
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CDK9 prevents mechanical injury-induced inflammation, apoptosis and matrix degradation in cartilage explants.
Hu Z; Yik JH; Cissell DD; Michelier PV; Athanasiou KA; Haudenschild DR
Eur Cell Mater; 2016; 30():200-9. PubMed ID: 26859911
[TBL] [Abstract][Full Text] [Related]
19. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X
Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel isoform of Cdk9.
Shore SM; Byers SA; Maury W; Price DH
Gene; 2003 Mar; 307():175-82. PubMed ID: 12706900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
